webinar register page

Webinar banner
Our Landmark Partnership with Break Through Cancer
Break Through Cancer has embarked on a new approach to research by tackling the deadliest cancers through “radical collaboration.”

Lustgarten has partnered with Break Through Cancer to tackle the toughest challenges including “Conquering KRAS.” The KRAS protein is altered in more than 90% of Pancreas cancers but has long been thought to be “undruggable.” With many promising new KRAS-targeting therapies on the horizon, the field may be on the cusp of a revolution in treatment for patients with pancreatic cancer. Lustgarten’s Conquering KRAS in Pancreatic Cancer project is addressing the challenge from all angles.

Understanding how Pancreatic cancer starts, progresses, and ultimately how to stop it requires understanding where tumor cells form and how they interact with their environment. To lift the veil on the secrets of pancreatic cancer, the Lustgarten Foundation supported Demystifying Pancreatic Cancer Therapies team is developing and deploying state-of-the-art tools to perform world-class science on patient samples, bringing the bench to the bedside.

Join Andrew Rakeman PhD, Vice President of Research, together with Andrew Aguirre MD, PhD and Laura Wood, MD, PhD, as they discuss how Break Through Cancer is empowering outstanding researchers and physicians to both intercept and find cures for Pancreatic cancer by stimulating radical collaboration.

This is must-see Lustgarten LIVE!


Feb 16, 2023 11:30 AM in Eastern Time (US and Canada)

* Required information